首页> 外文期刊>European journal of gastroenterology and hepatology >A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicen
【24h】

A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicen

机译:对有症状性反流性食管炎的奥美拉唑20 mg,兰索拉唑30 mg和pan托拉唑40 mg进行双盲,随机比较,然后进行3个月的奥美拉唑MUPS维持治疗:荷兰人multicen

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Proton pump inhibitors (PPIs) have proved to be effective in treating reflux oesophagitis. Until now, no study had compared the PPIs omeprazole Multiple Unit Pellet System (MUPS), lansoprazole and pantoprazole in patients with reflux oesophagitis. AIM : To compare omeprazole MUPS 20 mg, lansoprazole 30 mg and pantoprazole 40 mg for treatment effect in symptomatic reflux oesophagitis. METHOD : Patients with grade I-IV symptomatic reflux oesophagitis were randomized to double-blind omeprazole 20 mg once morning, lansoprazole 30 mg o.m. or pantoprazole 40 mg o.m. Patient satisfaction and symptoms were evaluated after 4 and 8 weeks. Patients not satisfied after 8 weeks were treated for another 4 weeks with omeprazole 40 mg MUPS (open). Successful treatment was followed by 3 months' maintenance treatment with omeprazole MUPS 20 mg (patients satisfied after 4 or 8 weeks) or omeprazole MUPS 40 mg (patients satisfied after 12 weeks). RESULTS : On intention-to-treat (ITT) analysis (n = 461) at 4 and 8 weeks, respectively, 84% and 87% (omeprazole MUPS), 78% and 81% (lansoprazole), and 84% and 89% (pantoprazole) were free of heartburn. Equivalence was found between omeprazole MUPS and pantoprazole (heartburn relief), but not with lansoprazole. Patient satisfaction after 4 and 8 weeks, respectively, was 79% and 89% (omeprazole MUPS), 76% and 86% (lansoprazole), and 79% and 91% (pantoprazole). Patient satisfaction was similar in all treatment groups. During maintenance, 87% in the omeprazole MUPS 20 mg group and 81% in the omeprazole MUPS 40 mg group were satisfied after 3 months. CONCLUSIONS : Omeprazole MUPS 20 mg and pantoprazole 40 mg have equivalent efficacy in the treatment of reflux oesophagitis. Based on patient satisfaction, omeprazole MUPS 20 mg, lansoprazole 30 mg and pantoprazole 40 mg are equally effective.
机译:背景:质子泵抑制剂(PPI)已被证明可有效治疗反流性食管炎。迄今为止,尚无研究比较反流性食管炎患者的PPI奥美拉唑多药丸系统(MUPS),兰索拉唑和pan托拉唑。目的:比较奥美拉唑MUPS 20毫克,兰索拉唑30毫克和pan托拉唑40毫克在症状性反流性食管炎中的治疗效果。方法:I-IV级症状性反流性食管炎患者随机分为双盲奥美拉唑20 mg,晨间一次,兰索拉唑30 mgo.m。或pan托拉唑40 mg o.m.在4周和8周后评估患者的满意度和症状。 8周后不满意的患者再用奥美拉唑40 mg MUPS(开放治疗)再治疗4周。成功治疗后,进行3个月维持治疗,分别使用奥美拉唑MUPS 20 mg(4周或8周后患者满意)或奥美拉唑MUPS 40 mg(12周后患者满意)。结果:在第4周和第8周进行意向性治疗(ITT)分析(n = 461)时,分别为84%和87%(奥美拉唑MUPS),78%和81%(兰索拉唑),84%和89% (pan托拉唑)无烧心感。在奥美拉唑MUPS和pan托拉唑(缓解胃灼热)之间发现了等效性,但与兰索拉唑未发现等效性。 4周和8周后,患者满意度分别为79%和89%(奥美拉唑MUPS),76%和86%(兰索拉唑)以及79%和91%(pan托拉唑)。所有治疗组的患者满意度均相似。维持期间,三个月后,奥美拉唑MUPS 20 mg组的满意率为87%,奥美拉唑MUPS 40 mg组的满意率为81%。结论:奥美拉唑MUPS 20毫克和pan托拉唑40毫克在反流性食管炎的治疗中具有相同的疗效。根据患者的满意度,奥美拉唑MUPS 20毫克,兰索拉唑30毫克和pan托拉唑40毫克同样有效。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号